BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
4/19/2018 7:56:07 AM | Browse: 1246 | Download: 1510
 |
Received |
|
2018-01-31 21:06 |
|
Peer-Review Started |
|
2018-02-01 03:34 |
|
To Make the First Decision |
|
2018-02-24 00:47 |
|
Return for Revision |
|
2018-02-24 06:55 |
|
Revised |
|
2018-03-13 22:10 |
|
Second Decision |
|
2018-03-30 09:00 |
 |
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2018-03-30 19:00 |
|
Articles in Press |
|
2018-03-30 19:00 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2018-04-18 06:06 |
|
Publish the Manuscript Online |
|
2018-04-19 07:56 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2018. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Minireviews |
| Article Title |
Multiomics biomarkers for the prediction of nonalcoholic fatty liver disease severity
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Carlos J Pirola and Silvia Sookoian |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Agencia Nacional de Promoción Científicay Tecnológica |
PICT 2014-0432 |
| Agencia Nacional de Promoción Científicay Tecnológica |
PICT 2014-1816 |
| Agencia Nacional de Promoción Científicay Tecnológica |
PICT 2015-0551 |
|
| Corresponding Author |
Silvia Sookoian, MD, PhD, Senior Scientist, Clinical and Molecular Hepatology, University of Buenos Aires, Institute of Medical Research A Lanari, Buenos Aires, Argentina, National Scientific and Technical Research Council−University of Buenos Aires. Institute of Medical Research, Combatientes de Malvinas 3150, Buenos Aires 1427, Argentina., CABA 1427, Argentina. ssookoian@intramed.net |
| Key Words |
Nonalcoholic steatohepatitis; Fibrosis; Liver biopsy; Genetics; PNPLA3; TM6SF2; Metabolomics; Proteomics; Transcriptomics; Nonalcoholic fatty liver disease; miR122 |
| Core Tip |
It is expected that, in the near future, nonalcoholic fatty liver disease patients can be diagnosed and treated according to their own “molecular signature”. Specific focus should be placed on prevention and early diagnosis through the application of biomarkers of disease risk. Selection of “personalized drugs” as well as tailored therapy according to the specific molecular signature should be further guaranteed. |
| Publish Date |
2018-04-19 07:56 |
| Citation |
Pirola CJ, Sookoian S. Multiomics biomarkers for the prediction of nonalcoholic fatty liver disease severity. World J Gastroenterol 2018; 24(15): 1601-1615 |
| URL |
http://www.wjgnet.com/1007-9327/full/v24/i15/1601.htm |
| DOI |
http://dx.doi.org/10.3748/wjg.v24.i15.1601 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
